Bavarian Nordic (OTCMKTS:BVNRY) Shares Gap Up – Should You Buy?

Bavarian Nordic (OTCMKTS:BVNRY)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $10.6050, but opened at $11.22. Bavarian Nordic shares last traded at $11.21, with a volume of 6,054 shares trading hands.

Bavarian Nordic Stock Up 5.8%

The firm has a 50 day moving average of $10.01 and a 200 day moving average of $9.80. The firm has a market cap of $2.69 billion, a price-to-earnings ratio of 11.42 and a beta of 1.20.

Bavarian Nordic (OTCMKTS:BVNRY) last issued its earnings results on Friday, August 21st. The company reported $0.46 earnings per share for the quarter. Bavarian Nordic had a return on equity of 11.97% and a net margin of 24.36%.The business had revenue of $316.47 million during the quarter.

Bavarian Nordic Company Profile

Bavarian Nordic A/S (OTCMKTS:BVNRY) is a Danish biotechnology company that develops, manufactures and commercializes vaccines for infectious diseases. The company serves government agencies, military organizations, healthcare providers and travelers, with products distributed across Europe, North America and other international markets.

Its best-known product is JYNNEOS, also marketed as IMVAMUNE or IMVANEX in certain regions, a non-replicating smallpox and mpox vaccine. Bavarian Nordic also offers vaccines for rabies and tick-borne encephalitis, including RabAvert and Rabipur for rabies prevention and Encepur for protection against tick-borne encephalitis.